UCB NORDIC A/S: Financial statements 2025
CVR: 26688949
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. That is an increase of 4.1% compared with the year before. Equity in the 2025 report amounted to DKK 18,047,000. The solvency ratio was 18.4%. The company had 44 employees in the financial year.
- Gross Profit
- DKK 88,278,000
- Profit/Loss
- DKK 6,014,000
- Equity
- DKK 18,047,000
- Total Assets
- DKK 98,198,000
- Employees
- 44
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 88.3M | 6M | 18M | 44 |
| 2024 | - | 84.8M | 5.2M | 17.3M | 43 |
| 2023 | - | 66.9M | 3.9M | 16.1M | 42 |
| 2022 | - | 61.5M | 4M | 15.1M | 40 |
| 2021 | - | 60.5M | 3M | 14.1M | 40 |
Official annual report
How creditworthy is UCB NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
UCB NORDIC A/S has won the tender "Amgros 2026 1.469.a" issued by Amgros I/S worth 221,000,000 DKK.
UCB NORDIC A/S has won the tender "Amgros 2026 1.1202.a" issued by Amgros I/S worth 383,606,720 DKK.
UCB NORDIC A/S has published its annual report for 2024. Gross profit came to DKK 84,780,000, and the net result was DKK 5,226,000.
UCB NORDIC A/S has won the tender "Amgros 2025 1.350.a" issued by Amgros I/S worth 20,097,600,000 DKK.
As of January 8, 2025, Christina Dyreborg Jeppesen has joined the board of directors of UCB NORDIC A/S.
As of January 8, 2025, Laura Ann Byram has joined the board of directors of UCB NORDIC A/S.
As of January 8, 2025, Jaana Mattila has joined the board of directors of UCB NORDIC A/S.
As of January 8, 2025, Per Ove Jonas Berg has left the board of directors of UCB NORDIC A/S.
As of January 8, 2025, Afshin Risseh has left the board of directors of UCB NORDIC A/S.
As of January 8, 2025, Ana Isabel Infante Gonzalez De La Aleja has left the board of directors of UCB NORDIC A/S.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.